New study finds the unexpected benefits of anti-obesity drugs for transplant patients
A new study reveals that anti-obesity drugs can help kidney transplant recipients with type 2 diabetes reduce the risk of organ failure and increase survival rates. Researchers found that GLP-1 agonists were effective but recommended monitoring for diabetic retinopathy due to an increased risk.
A new study reveals that anti-obesity drugs can help kidney transplant recipients with type 2 diabetes reduce the risk of organ failure and increase survival rates. Researchers found that GLP-1 agonists were effective but recommended monitoring for diabetic retinopathy due to an increased risk.
